Register your email address to show your organization how much you value your AdisInsight subscription.
With your consent we’ll provide this information to your organization’s account administrator to aid in the renewal decision and we will send you important updates about AdisInsight.
Please refer to our
privacy policy
for information on how we protect your personal information.
Enter e-mail address here
Enter valid e-mail address
You will receive an email to validate your email address.
You will see this pop-up again if your browser cookies are cleared on your computer.
Observational study of treatment of epidermal growth factor receptor activating mutation positive (EGFRm+) advanced or recurrent non-small-cell lung cancer
Observational study of treatment of epidermal growth factor receptor activating mutation positive (EGFRm+) advanced or recurrent non-small-cell lung cancer
Status:Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update:07 Dec 2015
Price :
$35
*
Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.